Optimized post-GWAS analysis identifies therapeutic targets for essential thrombocythemia and polycythemia vera

Xiaoli Li, Wenbin An, Xin Wang, Zixi Yin, Yangyang Gao, Yang Lan, Luyang Zhang, Beibei Zhao, Lixian Chang, Min Ruan, Li Zhang, Yao Zou, Wenyu Yang, Xiaofan Zhu · 2026

Read Optimized post-GWAS analysis identifies therapeutic targets for essential thrombocythemia and polycythemia vera by Xiaoli Li, Wenbin An, Xin Wang, Zixi Yin, Yangyang Gao, Yang Lan, Luyang Zhang, Beibei Zhao, Lixian Chang, Min Ruan, Li Zhang, Yao Zou, Wenyu Yang, Xiaofan Zhu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13272951.txt.

Description

Xiaoli Li leads a 2026 genetics study seeking treatment targets for two blood disorders marked by excess blood cell production. In essential thrombocythemia, platelets run high; in polycythemia vera, red cells run high. The team used a post-GWAS framework that joins gene data with causal inference methods to rank molecular drivers.

Higher predicted levels of five proteins linked to risk of both disorders, while one gene, MYB, linked only to the platelet disorder. Several markers also changed platelet, red cell, and white cell counts in distinct patterns. Two DNA marks lowered one key protein and raised risk for both disorders, pointing to shared and separate pathways for therapy.

Catalog record

CREATORXiaoli Li, Wenbin An, Xin Wang, Zixi Yin, Yangyang Gao, Yang Lan, Luyang Zhang, Beibei Zhao, Lixian Chang, Min Ruan, Li Zhang, Yao Zou, Wenyu Yang, Xiaofan Zhu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE58303
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13272951

Browse the full library · About the Tower of Babel